Veris Residential (VRE) Form 144 Filed for 106,897-Share Sale

Rhea-AI Filing Summary

Form 144 notice shows a proposed sale of 106,897 shares of common stock of Veris Residential, Inc. (VRE) with an aggregate market value of $1,706,531.26. The sale is planned to occur on or about 09/12/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The filing reports the issuer has 93,421,769 shares outstanding.

The shares to be sold were acquired in several open-market purchases in November 2018 in lots (e.g., 3,752; 25,052; 46,123; 29,203; 2,767) paid in cash. The filing also lists multiple sales of the issuer's common stock by entities named MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC on 09/09–09/11/2025, with individual sale amounts ranging from 64,080 to 114,560 shares and gross proceeds per trade reported. The filer certifies no undisclosed material adverse information is known.

Positive

• Clear disclosure of the proposed sale amount (106,897 shares) and aggregate market value ($1,706,531.26).
• Brokered sale via Morgan Stanley Smith Barney LLC, suggesting an orderly transaction on the NYSE.
• Detailed acquisition history showing open-market purchases and cash payment, supporting Rule 144 compliance.

Negative

• None.

Insights

Securities Analyst

Routine Rule 144 disposition by an affiliated holder; limited market impact given size relative to float.

The notice documents a planned sale of 106,897 shares (~0.11% of the reported 93.4 million shares outstanding) via a recognized broker on the NYSE, indicating an orderly, brokered disposition under Rule 144. The lots were acquired in November 2018 via open-market purchases and paid in cash, which supports the filer’s compliance with holding-period requirements. Recent sales by related entities between 09/09 and 09/11/2025 show multiple sizable transactions, with gross proceeds reported for each trade, but the amounts are modest relative to total shares outstanding. Overall, this filing is procedural and informational for investors tracking insider/affiliate selling activity.

Corporate Governance Expert

Disclosure is complete and conforms to Rule 144 requirements; no governance red flags in the notice itself.

The form provides required broker, acquisition, and sale-history details and includes the standard attestation about material nonpublic information. The use of a major broker and itemized acquisition dates/amounts indicates transparent reporting. Multiple related-entity sales in the immediately preceding days are disclosed, which investors may monitor, but the filing does not allege any undisclosed operational or governance issues. As a standalone document, it is a routine compliance filing rather than a governance event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	106897	1706531.26	93421769	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/05/2018	Open Market Purchase	Open Market			3752	11/07/2018	Cash
Common	11/20/2018	Open Market Purchase	Open Market			25052	11/22/2018	Cash
Common	11/15/2018	Open Market Purchase	Open Market			46123	11/19/2018	Cash
Common	11/16/2018	Open Market Purchase	Open Market			29203	11/20/2018	Cash
Common	11/19/2018	Open Market Purchase	Open Market			2767	11/21/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	114560	1840956.29
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/11/2025	85440	1373003.71
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	85920	1378491.89
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/10/2025	64080	1028093.11
MIRELF VI REIT INVESTMENT II, LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	64080	1032924.74
MIRELF VII US SECURITIES LLC Harborside 3, 210 Hudson St. Ste. 400 Jersey City NJ 07311	Common	09/09/2025	85920	1384970.29

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of VRE are proposed for sale under this Form 144?

The filer proposes to sell 106,897 common shares of Veris Residential, Inc.

What is the aggregate market value and planned sale date for the VRE shares?

Aggregate market value is reported as $1,706,531.26, with an approximate sale date of 09/12/2025.

Which broker and exchange will handle the VRE sale?

The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

When were the shares being sold originally acquired?

The reported lots were acquired in November 2018 via open-market purchases (examples: 11/05/2018; 11/15/2018; 11/20/2018).

Have related entities sold VRE shares recently?

Yes. The filing lists multiple sales by MIRELF VII US SECURITIES LLC and MIRELF VI REIT INVESTMENT II, LLC on 09/09–09/11/2025 with individual trades from 64,080 to 114,560 shares and reported gross proceeds per trade.